Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 33
Filtrer
1.
Food Funct ; 13(11): 6195-6204, 2022 Jun 06.
Article de Anglais | MEDLINE | ID: mdl-35583033

RÉSUMÉ

Microbiota is known to play a pivotal role in generating bioavailable and bioactive low-molecular-weight metabolites from dietary polyphenols. 5-O-caffeoylquinic acid (5-CQA), one of the main polyphenols found in human diet, was submitted to a resting cell biotransformation study using three gut bacteria species Lactobacillus reuteri, Bacteroides fragilis and Bifidobacterium longum. These bacteria were selected according to their belonging to the main phyla found in human gut microbiota. Our study highlighted the ability of only one of the strains studied, L. reuteri, to bioconverse 5-CQA into various metabolites due to the expression of the cinnamoyl esterase enzyme as the first step. Interestingly, one known natural compound, esculetin, was described for the first time as a 5-CQA-derived metabolite after conversion by a gut bacterium, the other metabolites had already been reported. This evidence highlighted an interesting oxidative pathway occurring in vivo by intestinal microbiota leading to esculetin. This molecule was also identified after electrochemical and enzymatic oxidations of caffeic acid. The oxidation capacity of L. reuteri led to less diverse metabolites in comparison to those obtained either electrochemically and enzymatically where dimers and trimers were reported. Thus, esculetin may have interesting and benefical biological effects on gut microbiota, which should be further evaluated. Novel synbiotics could be formulated from the association of L. reuteri with 5-CQA.


Sujet(s)
Limosilactobacillus reuteri , Polyphénols , Bactéries/métabolisme , Biotransformation , Acide chlorogénique/analogues et dérivés , Humains , Limosilactobacillus reuteri/métabolisme , Stress oxydatif , Polyphénols/pharmacologie , Acide quinique/analogues et dérivés
2.
Prog Urol ; 23(5): 336-46, 2013 Apr.
Article de Français | MEDLINE | ID: mdl-23545009

RÉSUMÉ

INTRODUCTION: Intravesical instillations of BCG remains the gold standard for intermediate and high risk NMIBC management. Maintenance treatment is recommended, however, the frequency of side effects responsible for the discontinuation of maintenance therapy over four out of five patients before the third year suggest a reduction or even spacing instillations. The objective of the study URO-BCG-4 was the evaluation of a new maintenance schedule by intravesical instillations of BCG combined reduced dose (third dose) and a decrease number of instillations per cycle (two or three). MATERIAL AND METHODS: Multicenter study of the French Association Oncologic Committee (12 university hospital centers), randomized, prospective, comparing reference diagram of BCG maintenance therapy one third of usual dose (group I) to a regimen combining third dose and decrease the number of instillations per cycle (two instead of three) (group II). We present the preliminary results at 1year of this Program of Clinical Research (CHU Rouen Promoter 2003-081). RESULTS: The rate of recurrence was respectively 9 and 7% (P=0.678) in groups I and II. The rate of tumor progression are 3 and 2.8% in groups I and II (P=1). Tolerance of intravesical instillations of BCG scored according to the WHO classification (Geneva 1979) was similar in the two groups. CONCLUSION: The decrease in the BCG dose (third dose) and the changes in the number and rate of instillations did not alter free tumor recurrence survival. The toxicity of intravesical instillations of BCG was identical in both groups. The use of the WHO classification has shown its limitations in the study of side effects of BCG as too complex and often not exhaustive. The rate of increase muscle was comparable in the two groups; however, a larger clinical experience is required.


Sujet(s)
Adjuvants immunologiques/usage thérapeutique , Vaccin BCG/usage thérapeutique , Chimiothérapie de maintenance , Tumeurs de la vessie urinaire/traitement médicamenteux , Administration par voie vésicale , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Femelle , Études de suivi , Humains , Mâle , Adulte d'âge moyen , Études prospectives , Facteurs temps
3.
Genetics ; 185(1): 245-55, 2010 May.
Article de Anglais | MEDLINE | ID: mdl-20194968

RÉSUMÉ

The waved with open eyes (woe) locus is a spontaneous recessive mouse mutation that exhibits wavy fur, eyelids open at birth, and enlarged heart and esophagus. In this study, we confirmed the previously identified woe phenotypes and additionally identified anterior eye segment defects, absence of the meibomian glands, and defects in the semilunar cardiac valves. Positional cloning identified a C794T substitution in the Adam17 gene that ablates a putative exonic splicing enhancer (ESE) sequence in exon 7 resulting in aberrant Adam17 splicing. The predominant woe transcript, Adam17(Delta)(exon7), lacks exon 7 resulting in an in-frame deletion of 90 bp and a putative Adam17(Delta252-281) protein lacking residues 252-281 from the metalloprotease domain. Western blot analysis in woe identified only the precursor form of Adam17(Delta252-281) protein. Absence of cleavage of the prodomain renders Adam17(Delta252-281) functionally inactive; however, constitutive and stimulated shedding of Adam17 substrates was detected in woe at significantly reduced levels. This residual Adam17 shedding activity in woe most likely originates from full-length Adam17(T265M) encoded by the Adam17(C794T) transcript identified expressed at severely reduced levels. These results show that even small amounts of functional Adam17 allow woe mice to survive into adulthood. In contrast to Adam17(-/-) mice that die at birth, the viability of woe mice provides an excellent opportunity for studying the role of Adam17 throughout postnatal development and homeostasis.


Sujet(s)
Protéines ADAM/génétique , Locus génétiques/génétique , Mutation/génétique , Protéines ADAM/composition chimique , Protéine ADAM17 , Allèles , Épissage alternatif/génétique , Séquence d'acides aminés , Animaux , Séquence nucléotidique , Clonage moléculaire , Embryon de mammifère/cytologie , Oeil/métabolisme , Oeil/anatomopathologie , Fibroblastes/métabolisme , Souris , Données de séquences moléculaires , Myocarde/métabolisme , Myocarde/anatomopathologie , Phénotype
4.
Vet Microbiol ; 137(3-4): 306-12, 2009 Jun 12.
Article de Anglais | MEDLINE | ID: mdl-19201550

RÉSUMÉ

Hypermutation is an important mechanism used by different Salmonella enterica subspecies enterica to regulate genetic stability in adaptation to changing environments, including antimicrobial treatments and industrial processes. Strong hypermutator strains generally contain a mutation in genes of the methyl mismatch repair (MMR) system and have mutation frequencies up to 1000-fold higher than wild type strains. The objectives of this study were to determine the distribution of mutation frequencies from a collection of 209 Salmonella strains, to genetically characterize a strong mutator, and to study MMR mutated protein-DNA binding interactions. Only one strain of S. Heidelberg was determined to have a hypermutator phenotype by virtue of its high mutation rate. Sequencing of genes of the MMR system showed a 12bp deletion in the mutS gene was present. The MMR mutated protein-DNA binding interactions were studied by bioanalysis, using the available crystal structure of a similar MutS protein from Escherichia coli. This analysis showed the small deletion in the Salmonella MutS was localized within the core domain. A retardation assay with MutS from hypermutable and wild type strains showed this mutation has no effect on MutS DNA binding. A better understanding of the genetic mechanisms of hypermutation will help to anticipate the behavior of hypermutator strains in various conditions.


Sujet(s)
Salmonelloses/microbiologie , Salmonella enterica/génétique , Salmonella enterica/métabolisme , Animaux , Antibactériens/pharmacologie , Protéines bactériennes/génétique , Protéines bactériennes/métabolisme , Résistance bactérienne aux médicaments/génétique , Régulation de l'expression des gènes bactériens/physiologie , Humains , Mutation , Salmonella enterica/effets des médicaments et des substances chimiques
5.
Microb Ecol ; 53(4): 537-48, 2007 May.
Article de Anglais | MEDLINE | ID: mdl-17404788

RÉSUMÉ

The structure and summertime production of planktonic communities and the role of nondiatom planktonic cells were studied in coastal ponds, which are areas traditionally used for fattening and greening table-sized oysters. The abundance and biomass of nano-microplanktonic protists were determined at weekly intervals between February 1998 and February 1999 in a coastal pond without oysters in the French Atlantic coast near La Rochelle. The production of these microbiotas was determined in the summer period. The structure of plankton communities revealed the following observations: (1) microphytoplanktonic cells were mostly diatoms and dinoflagellates, (2) microzooplanktonic cells were mainly ciliates, and (3) nanoplanktonic cells were represented by pigmented (80-90% of the nanoplankton biomass) and colorless nanoflagellates. Diatoms were dominated by Naviculiineae. Dinoflagellates were dominated by Peridiniales. Oligotrichida were predominant in the ciliate community. Protist biomass levels were nine times higher from April to August (summer period 1033 microg C L(-1)) than from September to March (winter period 114 microg C L(-1)). Whatever the season, nanoflagellates were dominant in the water column (66 and 53% of the entire protist biomass in the summer and winter periods, respectively). Nanoflagellates represented the highest production of nano-microplanktonic communities (76% of carbon protist production) in the coastal pond in summer and showed the shortest generation time (7.1 h). Dinoflagellates came after nanoflagellates in production (19.5% of carbon protist production). Diatoms represented only a supplementary carbon resource available for higher trophic levels, whereas, until now, they were considered as the principal food of oysters in coastal ponds. Ciliates were a small source of carbon, but their growth rate was high. We suggest, first, that nanoflagellates represented the primary resource available in the pond and could constitute an important food resource for higher trophic levels, such as oysters, farmed in this type of pond. Overall, the system appeared to be more autotrophic than heterotrophic. Because inorganic nutrients are quickly exhausted in a semiclosed pond, pigmented flagellates dominated the carbon biomass, production and biomass of bacteria were high (thus, the microbial food web appeared to be active in this pond), and mixotrophy seemed to be an important trophic mode there.


Sujet(s)
Biodiversité , Plancton/croissance et développement , Saisons , Animaux , Océan Atlantique , Biomasse , Ciliophora/classification , Ciliophora/croissance et développement , Ciliophora/isolement et purification , Diatomées/classification , Diatomées/croissance et développement , Diatomées/isolement et purification , Dinoflagellida/classification , Dinoflagellida/croissance et développement , Dinoflagellida/isolement et purification , Plancton/classification , Plancton/isolement et purification , Température , Eau/composition chimique
7.
Presse Med ; 30(29): 1450-2, 2001 Oct 13.
Article de Français | MEDLINE | ID: mdl-11695056

RÉSUMÉ

BACKGROUND: Reduced visual acuity in patients with acute leucemia can result from many causes including an ocular localization. CASE REPORT: A patient previously treated for acute myeloblastic leucemia-5 (AML5) developed bilateral vision impairment related to a subretinal localization of the leucemia. Meningeal and bone marrow relapse followed. The subretinal localization responded only to massive systemic steroid treatment. DISCUSSION: Although asymptomatic, ocular localizations are frequent in leucemia. Their prognostic impact depends on the ocular structure involved and on the chronology of onset--early or late in the leucemia course. The underlying pathophysiological mechanism of ocular involvement remains unexplained but hyperleucocytosis at presentation may be a risk factor and would justify at least systematic specialized examinations and discussion of prophylactic treatment.


Sujet(s)
Leucémie aigüe monoblastique/complications , Tumeurs de la rétine/complications , Vision faible/étiologie , Adulte , Humains , Mâle , Récidive tumorale locale/complications
8.
Proc Natl Acad Sci U S A ; 98(21): 12144-9, 2001 Oct 09.
Article de Anglais | MEDLINE | ID: mdl-11593029

RÉSUMÉ

HIV-1-infected cells can avoid cytotoxic T lymphocyte killing by Nef-mediated down-regulation of surface MHC I. Here, we show that HIV-1 Nef inhibits MHC II restricted peptide presentation to specific T cells and thus may affect the induction of antiviral immune responses. Nef mediates this effect by reducing the surface level of mature (i.e., peptide-loaded) MHC II while increasing levels of immature MHC II, which are functionally incompetent because of their association with the invariant chain. Nef was the only HIV-1 gene product to possess this capacity, which was also observed in the context of the whole HIV-1 genome. Other proteins of the endocytic pathway were not affected by Nef expression, suggesting that Nef effects on MHC II did not result from a general alteration of the endocytic pathway. Response patterns to previously characterized mutations of Nef differed for Nef-induced modulation of mature and immature MHC II. Furthermore, the doses of Nef required to observe each of the two effects were clearly different, suggesting that Nef could affect MHC II peptide presentation through distinct mechanisms. Cooperation between those mechanisms may enable Nef to efficiently inhibit MHC II function.


Sujet(s)
Présentation d'antigène/immunologie , Produits du gène nef/immunologie , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/immunologie , Antigènes d'histocompatibilité de classe II/immunologie , Antigènes de différenciation des lymphocytes B/biosynthèse , Membrane cellulaire/immunologie , Régulation négative/immunologie , Expression des gènes , Produits du gène nef/génétique , Cellules HeLa , Antigènes d'histocompatibilité de classe II/biosynthèse , Humains , Produits du gène nef du virus de l'immunodéficience humaine
9.
J Virol ; 75(8): 3971-6, 2001 Apr.
Article de Anglais | MEDLINE | ID: mdl-11264386

RÉSUMÉ

The Nef protein from the human immunodeficiency virus (HIV) induces CD4 cell surface downregulation by interfering with the endocytic machinery. It has been recently proposed that binding of HIV type 1 Nef to the beta subunit of COPI coatomers participated in the Nef-induced CD4 downregulation through recognition of a novel diacidic motif found in the C-terminal disordered loop of Nef (V. Piguet, F. Gu, M. Foti, N. Demaurex, J. Gruenberg, J. L. Carpentier, and D. Trono, Cell 97:63-73, 1999). We have mutated the glutamate residues which formed this motif in order to document this observation. Surprisingly, mutation of the diacidic sequence of Nef did not significantly affect its ability (i) to interact with beta-COP, (ii) to downregulate CD4 cell surface expression, and (iii) to address an integral resident membrane protein containing Nef as the cytoplasmic domain to the endocytic pathway. Our results indicate that these acidic residues are not involved in the connection of Nef with the endocytic machinery through binding to beta-COP. Additional studies are thus required to characterize the residues of Nef involved in the binding to beta-COP and to evaluate the contribution of this interaction to the Nef-induced perturbations of membrane trafficking.


Sujet(s)
Antigènes CD4/métabolisme , Protéine du coatomère/métabolisme , Régulation négative , Produits du gène nef/composition chimique , Produits du gène nef/métabolisme , Acide glutamique/métabolisme , VIH-1 (Virus de l'Immunodéficience Humaine de type 1) , Sous-unités gamma du complexe protéique adaptateur , Motifs d'acides aminés , Substitution d'acide aminé , Transport biologique , Antigènes CD4/génétique , Antigènes CD8/génétique , Antigènes CD8/métabolisme , Endocytose , Produits du gène nef/génétique , Acide glutamique/génétique , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/génétique , Cellules HeLa , Humains , Structures macromoléculaires , Protéines membranaires/métabolisme , Mutation , Liaison aux protéines , Protéines de fusion recombinantes , Reproductibilité des résultats , Techniques de double hybride , Produits du gène nef du virus de l'immunodéficience humaine
11.
Nat Med ; 7(3): 344-9, 2001 Mar.
Article de Anglais | MEDLINE | ID: mdl-11231634

RÉSUMÉ

Dendritic cells and macrophages can process extracellular antigens for presentation by MHC-I molecules. This exogenous pathway may have a crucial role in the activation of CD8+ cytotoxic T lymphocytes during human viral infections. We show here that HIV-1 epitopes derived from incoming virions are presented through the exogenous MHC-I pathway in primary human dendritic cells, and to a lower extent in macrophages, leading to cytotoxic T-lymphocyte activation in the absence of viral protein synthesis. Exogenous antigen presentation required adequate virus-receptor interactions and fusion of viral and cellular membranes. These results provide new insights into how anti-HIV cytotoxic T lymphocytes can be activated and have implications for anti-HIV vaccine design.


Sujet(s)
Antigènes du VIH/immunologie , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/immunologie , Antigènes d'histocompatibilité de classe I/immunologie , Virion/immunologie , Réplication virale , Lignée cellulaire , Réactions croisées , Épitopes/immunologie , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/physiologie , Humains
12.
J Virol ; 74(19): 9256-66, 2000 Oct.
Article de Anglais | MEDLINE | ID: mdl-10982373

RÉSUMÉ

The human immunodeficiency virus type 1 Nef protein alters the post-Golgi stages of major histocompatibility complex class I (MHC-I) biogenesis. Presumed mechanisms involve the disclosure of a cryptic tyrosine-based sorting signal (YSQA) located in the cytoplasmic tail of HLA-A and -B heavy chains. We changed this signal for a prototypic sorting motif (YSQI or YSQL). Modified HLA-A2 molecules, termed A2-endo, displayed constitutively low surface levels and accumulated in a region close to or within the Golgi apparatus, a behavior reminiscent of wild-type HLA-A2 in Nef-expressing cells. However, several lines of evidence indicate that the action of prototypic signals on MHC-I trafficking differs from that of Nef. Internalization of surface A2-endo was more rapid and was associated with efficient recycling to the surface. A transdominant-negative mutant of dynamin-1 inhibited A2-endo constitutive internalization and Nef-induced CD4 down-regulation, whereas it did not affect the activity of Nef on MHC-I. Moreover, trafficking of A2-endo was still affected by the viral protein, indicating additive effects of prototypic signals and Nef. Therefore, distinct trafficking pathways regulate clathrin-dependent and Nef-induced MHC-I modulation.


Sujet(s)
Clathrine/physiologie , Produits du gène nef/physiologie , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/physiologie , Antigènes d'histocompatibilité de classe I/physiologie , Régulation négative , Appareil de Golgi/physiologie , Cellules HeLa , Humains , Transduction du signal , Réplication virale , Produits du gène nef du virus de l'immunodéficience humaine
13.
J Virol ; 74(11): 5310-9, 2000 Jun.
Article de Anglais | MEDLINE | ID: mdl-10799608

RÉSUMÉ

Nef is a myristoylated protein of 27 to 35 kDa that is conserved in primate lentiviruses. In vivo, Nef is required for high viral load and full pathological effects. In vitro, Nef has at least four activities: induction of CD4 and major histocompatibility complex (MHC) class I downregulation, enhancement of viral infectivity, and alteration of T-cell activation pathways. We previously reported that the Nef protein from human immunodeficiency virus type 1 interacts with a novel human thioesterase (hTE). In the present study, by mutational analysis, we identified a region of the Nef core, extending from the residues D108 to W124, that is involved both in Nef-hTE interaction and in Nef-induced CD4 downregulation. This region of Nef is located on the oligomer interface and is in close proximity to the putative CD4 binding site. One of the mutants carrying a mutation in this region, targeted to the conserved residue D123, was also found to be defective in two other functions of Nef, MHC class I downmodulation and enhancement of viral infectivity. Furthermore, mutation of this residue affected the ability of Nef to form dimers, suggesting that the oligomerization of Nef may be critical for its multiple functions.


Sujet(s)
Antigènes CD4/biosynthèse , Séquence conservée , Régulation négative/immunologie , Produits du gène nef/immunologie , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/immunologie , Antigène HLA-A2/biosynthèse , Thiolester hydrolases/immunologie , Séquence d'acides aminés , Membrane cellulaire/immunologie , Dimérisation , Produits du gène nef/composition chimique , Produits du gène nef/génétique , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/physiologie , Cellules HeLa , Humains , Données de séquences moléculaires , Mutagenèse dirigée , Oligopeptides/composition chimique , Oligopeptides/génétique , Oligopeptides/immunologie , Palmitoyl-coA hydrolase , Liaison aux protéines , Conformation des protéines , Produits du gène nef du virus de l'immunodéficience humaine
14.
Immunol Rev ; 168: 51-63, 1999 Apr.
Article de Anglais | MEDLINE | ID: mdl-10399064

RÉSUMÉ

The human and simian immunodeficiency viruses (HIV and SIV) downregulate the cell surface expression of CD4, their primary receptor, and of class I histocompatibility complex (MHC-I), a critical mediator of immune recognition. While the first of these effects seems important to preserve viral infectivity, the second likely promotes immune evasion. Three HIV-1 proteins, Nef, Env and Vpu, contribute to downregulate CD4, Env forms a complex with CD4 in the endoplasmic reticulum, thereby retaining the receptor in this compartment. Nef and Vpu, on the other hand, act as connectors between CD4 and specific intracellular trafficking pathways, targeting the receptor for degradation in the lysosome and the proteasome, respectively. Some of the downstream partners of the viral proteins in these events have been identified, and include the adaptor complex of clathrin-coated pits, the beta subunit of COP-I coatomer, and the ubiquitin pathway-related h-beta TrCP protein. HIV-induced MHC-I downregulation, mostly the effect of Nef, also reflects a redistribution of this receptor, with its accumulation in the Golgi. The modalities of this process, however, are as yet imperfectly understood. New evidence indicates that the mechanisms employed by primate lentiviruses to downmodulate CD4 and MHC-I are also exploited by a number of cellular regulatory processes.


Sujet(s)
Antigènes CD4/métabolisme , Régulation négative , Antigènes d'histocompatibilité de classe I/métabolisme , Lentivirus/métabolisme , Récepteurs viraux/métabolisme , Complexe protéique adaptateur, sous-unités alpha , Protéines adaptatrices du transport vésiculaire , Animaux , Produits du gène nef/métabolisme , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/métabolisme , Protéines du virus de l'immunodéficience humaine , Humains , Liquide intracellulaire/métabolisme , Lysosomes/métabolisme , Protéines membranaires/métabolisme , Primates , Protéines de l'enveloppe virale/métabolisme , Protéines virales régulatrices ou accessoires/métabolisme , Produits du gène nef du virus de l'immunodéficience humaine
15.
Immunity ; 8(4): 483-95, 1998 Apr.
Article de Anglais | MEDLINE | ID: mdl-9586638

RÉSUMÉ

The surface expression of MHC I is reduced in HIV-infected cells. We show that the Nef protein affects the intracellular sorting of HLA-A and -B molecules. In the presence of Nef, these proteins accumulate in the Golgi and colocalize with clathrin-coated vesicles. MHC I modulation relies on a tyrosine-based sorting signal located in the cytoplasmic domain of HLA-A and -B heavy chains. This cryptic sorting signal becomes operative only in the presence of Nef. Nef interacts with the medium (mu) subunit of AP adaptor complexes involved in the recognition of tyrosine-based sorting signals, likely facilitating the connection between MHC I and the clathrin-dependent sorting machinery.


Sujet(s)
Clathrine/métabolisme , Produits du gène nef/métabolisme , Antigènes HLA-A/métabolisme , Antigènes HLA-B/métabolisme , Complexe protéique adaptateur, sous-unités alpha , Protéines adaptatrices du transport vésiculaire , Séquence d'acides aminés , Sites de fixation , Antigènes CD4/métabolisme , Clathrine/composition chimique , Régulation négative , Infections à VIH/métabolisme , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/métabolisme , VIH-2 (Virus de l'Immunodéficience Humaine de type 2)/métabolisme , Antigènes HLA-A/composition chimique , Antigènes HLA-A/génétique , Antigènes HLA-B/composition chimique , Antigènes HLA-B/génétique , Antigènes HLA-C/composition chimique , Antigènes HLA-C/génétique , Antigènes HLA-C/métabolisme , Cellules HeLa , Humains , Protéines membranaires/composition chimique , Protéines membranaires/métabolisme , Modèles biologiques , Données de séquences moléculaires , Conformation des protéines , Transduction du signal , Virus de l'immunodéficience simienne/métabolisme , Produits du gène nef du virus de l'immunodéficience humaine
16.
J Biol Chem ; 272(21): 13779-85, 1997 May 23.
Article de Anglais | MEDLINE | ID: mdl-9153233

RÉSUMÉ

Nef is a 27-kDa myristoylated protein conserved in primate lentiviruses. In vivo, simian immunodeficiency virus Nef is required in macaques to produce a high viral load and full pathological effects. Nef has at least three major effects in vitro, induction of CD4 down-regulation, alteration of T cell activation pathways, and enhancement of viral infectivity. We have used the yeast two-hybrid system to identify cellular proteins that interact with HIV-1Lai Nef and could mediate Nef function. A human cDNA was isolated that encodes a new type of thioesterase, an enzyme that cleaves thioester bonds. This novel thioesterase is unlike the animal types I and II thioesterases previously cloned but is homologous to the Escherichia coli thioesterase II. Nef and this thioesterase interact in vitro and are co-immunoprecipitated by anti-Nef antibodies in CEM cells expressing Nef. Nef alleles from human immunodeficiency virus-1 (HIV-1) isolates unable to down-regulate CD4 do not react or react poorly with thioesterase. An HIV-1 NefLai mutant selected for its lack of interaction with thioesterase was also unable to down-regulate CD4 cell-surface expression. These observations suggest that this human thioesterase is a cellular mediator of Nef-induced CD4 down-regulation.


Sujet(s)
Antigènes CD4/métabolisme , Régulation négative , Produits du gène nef/métabolisme , VIH-1 (Virus de l'Immunodéficience Humaine de type 1) , Thiolester hydrolases/métabolisme , Allèles , Séquence d'acides aminés , Clonage moléculaire , ADN complémentaire/composition chimique , Escherichia coli/enzymologie , Fatty acid synthases/génétique , Fatty acid synthases/métabolisme , Humains , Techniques in vitro , Cellules Jurkat , Données de séquences moléculaires , Palmitoyl-coA hydrolase , Protéines , Protéines recombinantes/métabolisme , Lymphocytes T/métabolisme , Thiolester hydrolases/génétique , Produits du gène nef du virus de l'immunodéficience humaine , T-RNA methyltransferases
17.
Virology ; 229(1): 295-301, 1997 Mar 03.
Article de Anglais | MEDLINE | ID: mdl-9123874

RÉSUMÉ

We have recently reported that HIV-1 Net down-regulates the cell surface expression of major histocompatibility complex class I (MHC-I) molecules. MHC-I molecules are one of the predominant cellular proteins associated with HIV-1 virions. Wild-type or nef-mutated HIV-1 virions were analyzed by immunoelectronic microscopy and Western blot for particle-associated MHC-I molecules. The number of MHC-I molecules was significantly higher in HIV-1 virions produced in the absence of Nef than in wild-type virions, indicating that Nef affects the incorporation of MHC-I molecules into virions. Wild-type HIV particles have been shown to be more infectious than Nef- viruses. This difference was maintained when Nef+ and Nef virions devoid of MHC-I molecules were produced in Daudi-CD4 cells. Therefore, the enhancement of virion infectivity and the down-regulation of MHC-I represent independent biological properties of Nef.


Sujet(s)
Produits du gène nef/physiologie , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/génétique , Antigènes d'histocompatibilité de classe I/physiologie , Virion/physiologie , Régulation négative , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/physiologie , Cellules HeLa , Antigènes d'histocompatibilité de classe I/ultrastructure , Humains , Microscopie immunoélectronique , Virion/ultrastructure , Virulence/physiologie , Produits du gène nef du virus de l'immunodéficience humaine
20.
Presse Med ; 25(20): 924-8, 1996 Jun 08.
Article de Français | MEDLINE | ID: mdl-8685155

RÉSUMÉ

OBJECTIVES: To review cases of alcoholic ketoacidosis in order to better ascertain therapeutic management. METHODS: The medical files of 32 alcoholic patients with ketoacidosis hospitalized in the Saint-Pierre general hospital of the Reunion island from January 1, 1991 through 31 August 1994 were analyzed. RESULTS: There were 18 women and 14 men, mean age 47 years. The first clinical signs were predominated by digestive (n = 22) or neurological disorders (n = 10). Acidosis was severe (mean pH = 7.12) and always associated with a wide anion gap (mean anion gap = 35). There were 3 types of glycemic status: hypoglycemia 10 cases, normal or subnormal glycemia in 19 cases (mean glycemia = 9.3 mmol/l) and hyperglycemia above 20 mmol/l in 3 cases. Hypophosphatemia, elevated serum lactate levels and cytolytic hepatitis were the main abnormalities associated. CONCLUSION: Short-term outcome was favorable in all cases after rehydration. The use of insulin may be dangerous and needs to be avoided.


Sujet(s)
Acidose/étiologie , Alcoolisme/complications , Cétose/étiologie , Acidose/sang , Acidose/physiopathologie , Adulte , Sujet âgé , Alcoolisme/sang , Alcoolisme/physiopathologie , Femelle , Hospitalisation , Humains , Cétose/sang , Cétose/physiopathologie , Mâle , Adulte d'âge moyen , Pronostic , Récidive , Études rétrospectives , Facteurs temps
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE